A RECENTLY published study by the University of the Philippines (UP) National Institutes of Health (NIH) funded by the Department of Science and Technology (DOST) revealed the latest local data that is reshaping the country’s cervical cancer prevention strategy, and experts say it should prompt immediate policy action to expand protection through the nonavalent HPV vaccine.